SCHEMBL4254491

SCHEMBL4254491

COC(=O)c1cc(=O)c2ccc(N)cc2o1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.72
AKR1B1 P15121 4/20 0.55
ALDH1A1 P00352 4/20 0.54
THRB P10828 1/20 0.52
GAA P10253 3/20 0.47
MAPT P10636 3/20 0.47
MAOB P27338 1/20 0.47
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
GLA P06280 1/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
CA9 Q16790 1/20 0.46
SLC2A1 P11166 1/20 0.45
POLB P06746 3/20 0.45
KMT2A Q03164 2/20 0.45
ABCB1 P08183 1/20 0.45
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4246461 0.88 KDM4E (0.59) KDM4EAKR1B1ALDH1A1THRBGAA
SCHEMBL4251463 0.85 AKR1B1 (0.75) KDM4EAKR1B1ALDH1A1THRBGAA
SCHEMBL8119217 0.85 AKR1B1 (0.74) KDM4EAKR1B1ALDH1A1THRBGAA
SCHEMBL4250653 0.84 KDM4E (0.52) KDM4EAKR1B1ALDH1A1THRBGAA
SCHEMBL4250015 0.84 AKR1B1 (0.76) KDM4EAKR1B1ALDH1A1THRBGAA
SCHEMBL29463588 0.84 KDM4E (0.70) KDM4EAKR1B1ALDH1A1THRBGAA
SCHEMBL9635473 0.84 KDM4E (0.70) KDM4EAKR1B1ALDH1A1THRBGAA
SCHEMBL8107875 0.84 KDM4E (1.00) KDM4EAKR1B1ALDH1A1GAAMAPT
SCHEMBL4251632 0.82 AKR1B1 (0.57) KDM4EAKR1B1ALDH1A1GAAMAPT
SCHEMBL4249673 0.82 MAOB (0.72) KDM4EAKR1B1ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101497571-B Process for producing chromone compound SUMITOMO CO LTD 2012-07-04 CN disclosed
CN-1911896-B Process for producing benzopyrone compound SUMITOMO CHEMICAL CO 2010-09-15 CN disclosed
EP-2105432-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
EP-2105431-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
CN-101497571-A Process for producing chromone compound SUMITOMO CHEMICAL CO (JP) 2009-08-05 CN disclosed
CN-100509751-C Process for producing benzopyranone compound SUMITOMO CHEMICAL CO (JP) 2009-07-08 CN disclosed
EP-1867626-A2 Process for producing chromone compound Sumitomo Chemical Company, Limited (JP) 2007-12-19 EP disclosed
CN-1911896-A Process for producing chromone compound SUMITOMO CHEMICAL CO (JP) 2007-02-14 CN disclosed
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed
US-7094914-B2 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-08-22 US disclosed
CN-1649824-A Process for producing benzopyranone compound SUMITOMO CHEMICAL CO (JP) 2005-08-03 CN disclosed
US-20050085664-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LMITED (JP) 2005-04-21 US disclosed
EP-1479667-A1 PROCESS FOR PRODUCING CHROMONE COMPOUND Sumitomo Chemical Company, Limited (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085664-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL KDM4E 978/4885AKR1B1 237/4885ALDH1A1 3157/4885
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL KDM4E 978/4885AKR1B1 237/4885ALDH1A1 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.